Equities research analysts predict that McKesson Corporation (NYSE:MCK) will announce $51.98 billion in sales for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for McKesson Corporation’s earnings, with the lowest sales estimate coming in at $51.51 billion and the highest estimate coming in at $52.46 billion. McKesson Corporation reported sales of $50.13 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 3.7%. The firm is expected to report its next quarterly earnings results on Wednesday, January 24th.

According to Zacks, analysts expect that McKesson Corporation will report full year sales of $51.98 billion for the current financial year, with estimates ranging from $204.58 billion to $205.95 billion. For the next financial year, analysts expect that the company will post sales of $209.00 billion per share, with estimates ranging from $203.19 billion to $211.93 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research firms that cover McKesson Corporation.

McKesson Corporation (NYSE:MCK) last issued its quarterly earnings results on Thursday, October 26th. The company reported $3.28 EPS for the quarter, topping analysts’ consensus estimates of $2.78 by $0.50. McKesson Corporation had a return on equity of 24.87% and a net margin of 2.24%. The firm had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.69 billion. During the same period in the previous year, the firm posted $2.94 EPS. The business’s revenue for the quarter was up 4.2% compared to the same quarter last year.

Several equities analysts recently issued reports on the company. BidaskClub cut McKesson Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Robert W. Baird raised McKesson Corporation from a “neutral” rating to an “outperform” rating and upped their price objective for the company from $175.00 to $178.00 in a research report on Tuesday, September 19th. Mizuho set a $168.00 price objective on McKesson Corporation and gave the company a “hold” rating in a research report on Tuesday, October 24th. TheStreet cut McKesson Corporation from a “b” rating to a “c+” rating in a research report on Friday, August 25th. Finally, ValuEngine raised McKesson Corporation from a “hold” rating to a “buy” rating in a research report on Tuesday, October 31st. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have given a buy rating to the company. McKesson Corporation currently has a consensus rating of “Hold” and a consensus price target of $174.27.

In other McKesson Corporation news, Chairman John H. Hammergren sold 225,000 shares of the business’s stock in a transaction on Friday, September 22nd. The shares were sold at an average price of $151.67, for a total transaction of $34,125,750.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Erin M. Lampert sold 900 shares of the business’s stock in a transaction on Thursday, September 7th. The shares were sold at an average price of $155.65, for a total transaction of $140,085.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 949,900 shares of company stock valued at $145,403,445. Company insiders own 1.20% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. raised its stake in McKesson Corporation by 8.0% during the 2nd quarter. BlackRock Inc. now owns 15,330,001 shares of the company’s stock valued at $2,522,396,000 after buying an additional 1,131,024 shares during the last quarter. Vanguard Group Inc. raised its stake in McKesson Corporation by 0.4% during the 2nd quarter. Vanguard Group Inc. now owns 14,090,544 shares of the company’s stock valued at $2,318,457,000 after buying an additional 62,004 shares during the last quarter. Ballentine Partners LLC purchased a new stake in McKesson Corporation during the 1st quarter valued at $191,000. Bank of New York Mellon Corp raised its stake in McKesson Corporation by 6.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 2,540,305 shares of the company’s stock valued at $390,217,000 after buying an additional 154,967 shares during the last quarter. Finally, Pzena Investment Management LLC increased its stake in shares of McKesson Corporation by 17.2% in the 3rd quarter. Pzena Investment Management LLC now owns 2,458,531 shares of the company’s stock worth $377,655,000 after purchasing an additional 360,676 shares in the last quarter. Institutional investors and hedge funds own 87.50% of the company’s stock.

WARNING: “$51.98 Billion in Sales Expected for McKesson Corporation (MCK) This Quarter” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.watchlistnews.com/51-98-billion-in-sales-expected-for-mckesson-corporation-mck-this-quarter/1723042.html.

Shares of McKesson Corporation (MCK) opened at $145.80 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.05 and a quick ratio of 0.61. McKesson Corporation has a 12-month low of $133.82 and a 12-month high of $169.29. The company has a market capitalization of $30,395.58, a P/E ratio of 11.99, a PEG ratio of 1.50 and a beta of 1.21.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Shareholders of record on Friday, December 1st will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $1.36 dividend on an annualized basis and a yield of 0.93%. McKesson Corporation’s dividend payout ratio is presently 6.45%.

McKesson Corporation Company Profile

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.

Get a free copy of the Zacks research report on McKesson Corporation (MCK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for McKesson Corporation (NYSE:MCK)

Receive News & Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.